OPTUS Pharmaceutical Co., Ltd.
Research OPTUS Pharmaceutical Co., Ltd. (131030.KQ) on Bullrun: market cap KRW 105.97B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker131030.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyKRW
- Market capKRW 105.97B
- Financial periodQ2 2026
- RevenueKRW 24.64B
- Net incomeKRW 3.90B
- Free cash flowKRW 6.06B
- Gross margin58.1%
Valuation Snapshot
latest market cap is KRW 105.97B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 105.97B | n/a | n/a | n/a |
About OPTUS Pharmaceutical Co., Ltd.
OPTUS Pharmaceutical Co., Ltd. provides ophthalmic solutions in South Korea. The company offers dry eye preparation, antibiotics, anti-allergic preparation, steroids preparation, glaucoma treatment, and retinopathy treatment products. It also provides ETC, OTC, cosmetics, healthcare, and other products, as well as single-dose unit eye drops and eye care products under OEU& brand name. The company was formerly known as DHP Korea Co., Ltd. OPTUS Pharmaceutical Co., Ltd.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is OPTUS Pharmaceutical Co., Ltd.'s market cap?
OPTUS Pharmaceutical Co., Ltd.'s market capitalization is KRW 105.97B.
What does OPTUS Pharmaceutical Co., Ltd. do?
OPTUS Pharmaceutical Co., Ltd. provides ophthalmic solutions in South Korea. The company offers dry eye preparation, antibiotics, anti-allergic preparation, steroids preparation, glaucoma treatment, and retinopathy treatment products. It also provides ETC, OTC, cosmetics, healthcare, and other products, as well as single-dose unit eye drops and eye care products under OEU& brand name. The company was formerly known as DHP Korea Co., Ltd. OPTUS Pharmaceutical Co., Ltd. was founded in 2002 and is headquartered in Cheongju, South Korea.